Clinical Trials Logo

Gastroesophageal Reflux clinical trials

View clinical trials related to Gastroesophageal Reflux.

Filter by:

NCT ID: NCT02135107 Completed - Clinical trials for Gastroesophageal Reflux Disease

A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

Start date: September 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of rabeprazole 10mg once and twice daily in maintenance therapy for PPI resistant gastroesophageal reflux disease patients.

NCT ID: NCT02128867 Completed - Clinical trials for Gastro-esophageal Reflux

Safety Study of Airway Clearance Techniques in Infants.

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether three airway clearance techniques ( Bouncing, Assisted Autogenic Drainage ( AAD) and bouncing and AAD) provoke or aggravate gastro-esophageal reflux in infants under the age of 1 year.

NCT ID: NCT02124863 Completed - Clinical trials for Gastro-oesophageal Reflux

Influence of IPV on GOR in Infants From 0 to 12 Months.

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Intrapulmonary Percussive Ventilation ( airway clearance technique) provokes or aggravates gastro-oesophageal reflux in infants from 0 to 12 months.

NCT ID: NCT02123498 Withdrawn - Clinical trials for Laryngopharyngeal Reflux

The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux

ETDLPR
Start date: n/a
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the relationship between ear fullness, pressure, and/or pain and laryngopharyngeal reflux, in order to focus medical therapy and improve therapeutic outcomes in this patient population.

NCT ID: NCT02114216 Completed - Clinical trials for Gastro-esophageal Reflux Disease

Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease

Start date: March 2013
Phase: N/A
Study type: Interventional

Transient receptor potential vanilloid-1 (TRPV1) receptor and proteinase-activated receptor 2 (PAR2) have been implicated in the mechanism of acid induced inflammation in gastroesophageal reflux disease (GERD). We aimed to evaluate TRPV1 and PAR2 mRNA expression levels in the GERD patients and their relationship with endoscopic findings and reflux symptoms.

NCT ID: NCT02100189 Completed - Weight Loss Clinical Trials

Esophageal Cytology With FISH in Detecting Esophageal Cancer

Start date: February 2014
Phase: N/A
Study type: Interventional

This clinical trial studies whether esophageal cytology plus fluorescence in situ hybridization (FISH) is equal to or better than esophago-gastro-duodenoscopy (EGD) or upper endoscopy for the early detection of esophageal cancer. Genes are the units of deoxyribonucleic acid (DNA) the chemical structure carrying genetic information that determine many human characteristics. Certain genes in cancer cells may determine how the tumor grows or spreads and how it may respond to different drugs. Part of this study is to test those genes in esophageal cells using FISH.

NCT ID: NCT02096458 Completed - Clinical trials for Gastroesophageal Reflux Disease

Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

Start date: February 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to measure the in-vivo disintegration time of a single dexlansoprazole delayed-release orally disintegrating (OD) tablet.

NCT ID: NCT02087345 Recruiting - Clinical trials for Gastroesophageal Reflux

Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion

Start date: December 15, 2018
Phase:
Study type: Observational

Dental erosions, the chemical dissolution of enamel without bacterial involvement, are considered to be an established complication of gastroesophageal reflux disease (GERD) by the Montreal global consensus statement. Given the high prevalence of dental erosions and the absence of any pH-impedance data or medical management guidelines for GERD-associated dental erosions, reflux characteristics will be characterized using questionnaires, endoscopy and esophageal pH-impedance testing, in successive patients dental erosions referred by dentists for evaluation of GERD. For assessment of the role of additional factors besides H+ activity in the refluxate, a sample of gastric juice will be aspirated during endoscopy and frozen for analysis of pepsin and other proteases. Prognostic factors for progression of dental erosions will be determined by repeating the evaluation after chronic dosing with esomeprazole 20mg twice-daily, which is prescribed to all patients.

NCT ID: NCT02083952 Recruiting - Clinical trials for Gastroesophageal Reflux

Impact of Swaddle Blanket on Gastroesophageal Reflux

Start date: February 2014
Phase: N/A
Study type: Interventional

Gastroesophageal reflux disease (GERD) has been reported in up to 85% of all infants born prematurely, and has been associated with a wide range of symptoms. These include irritability, pauses in breathing, heart rate drops, declines in oxygen levels, chronic lung disease, and delays in growth and development. A novel approach to the mangement of GERD in infants is the use of an abdominal band, applying gentle pressure and possibly reducing the reflux of acid from the stomach. The purpose of this study is to evaluate the impact of a swaddle blanket with an abdominal band insert on the incidence of infant apnea, bradycardia, oxygen declines, and pH (acid) changes.

NCT ID: NCT02081404 Completed - Clinical trials for Non-erosive Reflux Disease

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

Start date: March 1, 2009
Phase: N/A
Study type: Interventional

Gastroesophageal reflux disease (GERD), a common chronic disorder in the veteran population, is associated with drug costs exceeding $ 10 billion/year. Only 30-40% of patients with reflux symptoms have erosive esophagitis. The vast majority suffers from non erosive reflux disease (NERD), a condition in which standard endoscopy fails to identify any mucosal breaks and is unable to confirm the diagnosis. Unfortunately, a gold standard for the diagnosis of NERD does not exist. Narrow band imaging (NBI) utilizes spectral narrow band filters (incorporated into standard endoscopes) and helps to see abnormal areas not identified during standard endoscopy. Preliminary results have shown that NBI endoscopy may represent a significant improvement over standard endoscopy for the diagnosis of NERD. The purpose of this study is to accurately diagnosis non acid reflux disease by using a blue light (also known as NBI)upper endoscopy technique.